160 related articles for article (PubMed ID: 21169728)
1. Adiponectin and bone metabolism markers in female rowers: eumenorrheic and oral contraceptive users.
Jürimäe J; Vaiksaar S; Mäestu J; Purge P; Jürimäe T
J Endocrinol Invest; 2011 Dec; 34(11):835-9. PubMed ID: 21169728
[TBL] [Abstract][Full Text] [Related]
2. No effect of menstrual cycle phase and oral contraceptive use on endurance performance in rowers.
Vaiksaar S; Jürimäe J; Mäestu J; Purge P; Kalytka S; Shakhlina L; Jürimäe T
J Strength Cond Res; 2011 Jun; 25(6):1571-8. PubMed ID: 21399539
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and osteocalcin responses to rowing exercise, and the relationship to substrate oxidation in female rowers.
Jürimäe J; Vaiksaar S; Purge P; Jürimäe T
Physiol Int; 2016 Jun; 103(2):220-230. PubMed ID: 28639861
[TBL] [Abstract][Full Text] [Related]
4. Interactions between adipose, bone, and muscle tissue markers during acute negative energy balance in male rowers.
Jürimäe J; Rämson R; Mäestu J; Jürimäe T; Arciero PJ; Braun WA; LeMura LM; Von Duvillard SP
J Sports Med Phys Fitness; 2011 Jun; 51(2):347-54. PubMed ID: 21681172
[TBL] [Abstract][Full Text] [Related]
5. A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.
Straznicky NE; Barrington VE; Branley P; Louis WJ
J Hypertens; 1998 Mar; 16(3):357-68. PubMed ID: 9557929
[TBL] [Abstract][Full Text] [Related]
6. Effect of administration of monophasic oral contraceptive on the body composition and aerobic and anaerobic capacities of female athletes.
Nakamura M; Nose-Ogura S
J Obstet Gynaecol Res; 2021 Feb; 47(2):792-799. PubMed ID: 33336549
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive therapy reduces serum relaxin-2 in elite female athletes.
Nose-Ogura S; Yoshino O; Yamada-Nomoto K; Nakamura M; Harada M; Dohi M; Okuwaki T; Osuga Y; Kawahara T; Saito S
J Obstet Gynaecol Res; 2017 Mar; 43(3):530-535. PubMed ID: 28026087
[TBL] [Abstract][Full Text] [Related]
8. Serum iron availability, but not iron stores, is lower in naturally menstruating than in oral contraceptive athletes.
Alfaro-Magallanes VM; Romero-Parra N; Barba-Moreno L; Rael B; Benito PJ; Díaz ÁE; Cupeiro R; Peinado AB;
Eur J Sport Sci; 2023 Feb; 23(2):231-240. PubMed ID: 34904534
[TBL] [Abstract][Full Text] [Related]
9. Increased Adipose and Muscle Insulin Sensitivity Without Changes in Serum Adiponectin in Young Female Collegiate Athletes.
Kitaoka K; Takeuchi M; Tsuboi A; Minato S; Kurata M; Tanaka S; Kazumi T; Fukuo K
Metab Syndr Relat Disord; 2017 Jun; 15(5):246-251. PubMed ID: 28318384
[TBL] [Abstract][Full Text] [Related]
10. Metabolic effects of combined oral contraceptive preparations.
Singh BM; Nutter SA; Nattrass M
Contraception; 1987 Dec; 36(6):651-8. PubMed ID: 3128428
[TBL] [Abstract][Full Text] [Related]
11. Serum osteocalcin is associated with improved metabolic state via adiponectin in females versus testosterone in males. Gender specific nature of the bone-energy homeostasis axis.
Buday B; Pach FP; Literati-Nagy B; Vitai M; Vecsei Z; Koranyi L
Bone; 2013 Nov; 57(1):98-104. PubMed ID: 23886839
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.
Sheu WH; Hsu CH; Chen YS; Jeng CY; Fuh MM
Clin Endocrinol (Oxf); 1994 Feb; 40(2):249-55. PubMed ID: 8137525
[TBL] [Abstract][Full Text] [Related]
13. [The role of osteocalcin in the connection of bone and glucose metabolism in humans].
Buday B; Kulcsár E; Literáti Nagy B; Horváth T; Vitai M; Vecsei I; Bezzegh K; Kiss J; Péterfai E; Koltay L; Korányi L
Orv Hetil; 2008 Dec; 149(52):2453-61. PubMed ID: 19087913
[TBL] [Abstract][Full Text] [Related]
14. Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism.
Gravenstein KS; Napora JK; Short RG; Ramachandran R; Carlson OD; Metter EJ; Ferrucci L; Egan JM; Chia CW
J Clin Endocrinol Metab; 2011 Jun; 96(6):E884-90. PubMed ID: 21389141
[TBL] [Abstract][Full Text] [Related]
15. Body Composition Over the Menstrual and Oral Contraceptive Cycle in Trained Females.
Rael B; Romero-Parra N; Alfaro-Magallanes VM; Barba-Moreno L; Cupeiro R; Janse de Jonge X; Peinado AB;
Int J Sports Physiol Perform; 2021 Mar; 16(3):375-381. PubMed ID: 33004685
[TBL] [Abstract][Full Text] [Related]
16. Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls.
Russell M; Stark J; Nayak S; Miller KK; Herzog DB; Klibanski A; Misra M
Bone; 2009 Jul; 45(1):104-9. PubMed ID: 19344792
[TBL] [Abstract][Full Text] [Related]
17. Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes.
Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
Bone; 2016 Jan; 82():50-5. PubMed ID: 25888930
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptors in circulating erythrocytes and monocytes from women on oral contraceptives or pregnant women near term.
Tsibris JC; Raynor LO; Buhi WC; Buggie J; Spellacy WN
J Clin Endocrinol Metab; 1980 Oct; 51(4):711-7. PubMed ID: 6998996
[TBL] [Abstract][Full Text] [Related]
19. Bone metabolic marker concentrations across the menstrual cycle and phases of combined oral contraceptive use.
Martin D; Cooper SB; Tang JCY; Fraser WD; Sale C; Elliott-Sale KJ
Bone; 2021 Apr; 145():115864. PubMed ID: 33508495
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk Between Bone and Fat Tissue: Associations Between Vitamin D, Osteocalcin, Adipokines, and Markers of Glucose Metabolism Among Adolescents.
Giudici KV; Fisberg RM; Marchioni DML; Peters BSE; Martini LA
J Am Coll Nutr; 2017; 36(4):273-280. PubMed ID: 28443718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
